Literature DB >> 17554620

Multicore vesicles: hyperosmolarity and L-DOPA induce homotypic fusion of dense core vesicles.

Leslie A Sombers1, Marc M Maxson, Andrew G Ewing.   

Abstract

AIM: A fraction of vesicles in cells treated with hypertonic solution exhibit multiple dense cores and this is enhanced by treatment with L-3,4-dihydroxyphenylalanine (L-DOPA). These cells were examined to determine if the multicore vesicles are the product of endocytosis or homotypic fusion.
METHODS: Electron microscopy was used to determine the number of multicore vesicles and amperometry was used to examine if the multicore vesicles are a competent fraction of the readily releasable pool.
RESULTS: In this study, we observed that a substantial portion (15.3%) of large dense core vesicles in PC12 cells contained multiple cores in hypertonic saline loaded with L-DOPA, and amperometric measurements show a bimodal distribution of quantal sizes in treated cells.
CONCLUSIONS: The results suggest that the multicored vesicles are formed from homotypic fusion of LCDVs prior to exocytosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17554620      PMCID: PMC2167625          DOI: 10.1007/s10571-007-9156-y

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  13 in total

1.  Regulation of dopamine quantal size in midbrain and hippocampal neurons.

Authors:  Emmanuel N Pothos
Journal:  Behav Brain Res       Date:  2002-03-10       Impact factor: 3.332

2.  Correlation between vesicle quantal size and fusion pore release in chromaffin cell exocytosis.

Authors:  Christian Amatore; Stéphane Arbault; Imelda Bonifas; Yann Bouret; Marie Erard; Andy G Ewing; Leslie A Sombers
Journal:  Biophys J       Date:  2005-03-25       Impact factor: 4.033

3.  Osmotic swelling of phospholipid vesicles causes them to fuse with a planar phospholipid bilayer membrane.

Authors:  F S Cohen; M H Akabas; A Finkelstein
Journal:  Science       Date:  1982-07-30       Impact factor: 47.728

4.  VMAT-Mediated changes in quantal size and vesicular volume.

Authors:  T L Colliver; S J Pyott; M Achalabun; A G Ewing
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

5.  Voltammetric and pharmacological characterization of dopamine release from single exocytotic events at rat pheochromocytoma (PC12) cells.

Authors:  K D Kozminski; D A Gutman; V Davila; D Sulzer; A G Ewing
Journal:  Anal Chem       Date:  1998-08-01       Impact factor: 6.986

6.  Fusion pore modulation as a presynaptic mechanism contributing to expression of long-term potentiation.

Authors:  Sukwoo Choi; Jürgen Klingauf; Richard W Tsien
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-04-29       Impact factor: 6.237

7.  L-3,4-dihydroxyphenylalanine increases the quantal size of exocytotic dopamine release in vitro.

Authors:  E Pothos; M Desmond; D Sulzer
Journal:  J Neurochem       Date:  1996-02       Impact factor: 5.372

8.  Characterization of the immature secretory granule, an intermediate in granule biogenesis.

Authors:  S A Tooze; T Flatmark; J Tooze; W B Huttner
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

9.  Recovery of surface membrane in anterior pituitary cells. Variations in traffic detected with anionic and cationic ferritin.

Authors:  M G Farquhar
Journal:  J Cell Biol       Date:  1978-06       Impact factor: 10.539

10.  Cell-free protein sorting to the regulated and constitutive secretory pathways.

Authors:  S A Tooze; W B Huttner
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

View more
  2 in total

Review 1.  Chromogranins A and B as regulators of vesicle cargo and exocytosis.

Authors:  José D Machado; Jésica Díaz-Vera; Natalia Domínguez; Carmen M Alvarez; Marta R Pardo; Ricardo Borges
Journal:  Cell Mol Neurobiol       Date:  2010-11-03       Impact factor: 5.046

2.  The functional role of chromogranins in exocytosis.

Authors:  Natalia Domínguez; Judith Estévez-Herrera; Marta R Pardo; Daniel Pereda; José David Machado; Ricardo Borges
Journal:  J Mol Neurosci       Date:  2012-03-14       Impact factor: 3.444

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.